Patient-derived Organoid Pharmacotyping As A Predictive Tool for Therapeutic Selection in Pancreatic Ductal Adenocarcinoma.
Nicolson NG, Tandurella JA, Wu LW, Patel J, Morris E, Seppälä TT, Guinn S, Zlomke H, Shubert CR, Lafaro KJ, Burns WR, Cameron JL, He J, Fertig EJ, Jaffee EM, Zimmerman JW, Burkhart RA.
Nicolson NG, et al. Among authors: wu lw.
Ann Surg. 2024 Sep 4. doi: 10.1097/SLA.0000000000006517. Online ahead of print.
Ann Surg. 2024.
PMID: 39229726